SCHEMBL6505974

SCHEMBL6505974

Nc1cc(C(Br)C(=O)c2cccc(Br)c2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.44
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3892578 0.99 PARP1 (0.43) PARP1NPC1RAB9APKMMAPT
SCHEMBL6505647 0.85 PARP1 (0.43) PARP1NPC1RAB9APKMMAPT
SCHEMBL6500196 0.85 PARP1 (0.43) PARP1NPC1RAB9APKMMAPK1
SCHEMBL6508288 0.85 NOS3 (0.47) GABRPGABRDGABRA1GABRB1GABRG2
Bromide SCHEMBL3891895 0.85 GABRP (0.46) MAPTGABRPGABRDGABRA1GABRB1
Bromide SCHEMBL3888929 0.84 PARP1 (0.42) PARP1NPC1RAB9APKMMAPK1
Bromide SCHEMBL3889498 0.84 PARP1 (0.42) PARP1NPC1RAB9APKMMAPT
Bromide SCHEMBL3886815 0.84 CES2 (0.46) PARP1NPC1RAB9APKMGABRP
Bromide SCHEMBL3886670 0.84 NOS3 (0.46) PARP1GABRPGABRDGABRA1GABRB1
Bromide SCHEMBL3887674 0.83 CYP3A4 (0.38) MAPTMAPK1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 PARP1 3236/4885NPC1 1275/4885RAB9A 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.